VISTAGEN THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $9.9M | $74.6M | $68.1M |
| FY2023 | $9.0M | $21.1M | $16.6M |
| FY2024 | $9.4M | $123.7M | $119.2M |
| FY2025 | $14.0M | $84.3M | $67.1M |
| FY2026 | $13.0M | $48.6M | $30.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $9.9M | $74.6M | $68.1M |
| FY2023 | $9.0M | $21.1M | $16.6M |
| FY2024 | $9.4M | $123.7M | $119.2M |
| FY2025 | $14.0M | $84.3M | $67.1M |
| FY2026 | $13.0M | $48.6M | $30.8M |